Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pharmaceutical Vaneck ETF (PPH)

Pharmaceutical Vaneck ETF (PPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 176,652,300
  • Market Capitalization, $K 176,652
  • Shares Outstanding, K 3,338
  • 60-Month Beta 0.96
  • Price/Earnings ttm 26.16
  • Annual Dividend & Yield 1.08 (2.06%)
  • Most Recent Dividend 0.337 on 04/01/20
  • Management Fee 0.36%
  • Sectors:

    ETFs - Healthcare

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.90 +12.20%
on 03/23/20
63.19 -16.72%
on 03/04/20
-7.68 (-12.73%)
since 03/03/20
3-Month
46.90 +12.20%
on 03/23/20
68.02 -22.64%
on 02/12/20
-11.07 (-17.38%)
since 01/03/20
52-Week
46.90 +12.20%
on 03/23/20
68.02 -22.64%
on 02/12/20
-7.07 (-11.84%)
since 04/03/19

Most Recent Stories

More News
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 52.62 (-0.64%)
JNJ : 134.17 (+0.77%)
NVO : 59.84 (+0.89%)
PFE : 33.64 (+2.34%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
Pharma ETFs Gain on Healthy Q4 Earnings

Strong results led to solid trading in pharma ETFs over the past week.

PPH : 52.62 (-0.64%)
PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
Sector ETFs & Stocks to Gain/Lose on Coronavirus Outbreak

These sectors are directly related to the outbreak of Coronavirus in China in a positive or negative way,putting the spotlight on these ETFs and stocks.

UAL : 22.89 (-2.28%)
AAL : 9.39 (-6.66%)
DAL : 22.48 (-0.88%)
LVS : 37.92 (-5.84%)
WYNN : 48.50 (-7.92%)
UTX : 86.01 (-5.87%)
COPX : 11.38 (-1.04%)
JETS : 12.30 (-2.84%)
XHE : 68.25 (-2.14%)
BJK : 23.74 (-2.67%)
PPH : 52.62 (-0.64%)
SLX : 20.56 (-3.74%)
HTHT : 28.57 (-2.06%)
MAR : 59.08 (-6.22%)
H : 39.92 (-0.57%)
RM : 10.43 (-13.37%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 52.62 (-0.64%)
NVO : 59.84 (+0.89%)
ABBV : 73.37 (-2.34%)
BMY : 55.53 (+0.58%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
Pharma Sector Tops in October: Best ETFs & Stocks

Pharma sector wins in October, making these ETFs and stocks winners.

PPH : 52.62 (-0.64%)
XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
ALXN : 89.77 (-0.64%)
BIIB : 300.51 (-1.30%)
ACHN : 6.76 (+10.28%)
DERM : 18.75 (+0.05%)
GLYC : 2.11 (+1.44%)
RIGL : 1.4400 (+0.70%)
IRWD : 9.87 (-2.28%)
Pharma ETFs Set to Benefit Post Strong Q3 Earnings

Robust results led to solid trading in pharma ETFs in a month.

XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
PPH : 52.62 (-0.64%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
Announcing VanEck Vectors ETFs' September 2019 Distributions

VanEck announced today its distributions per share for its VanEck Vectors(R) exchange-traded funds.

PPH : 52.62 (-0.64%)
Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

Despite robust results, pharma ETFs have been trending downward in a month.

PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
PPH : 52.62 (-0.64%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
Announcing VanEck Vectors ETFs' June 2019 Distributions

VanEck announced today its distributions per share for its VanEck Vectors(R) exchange-traded funds.

PPH : 52.62 (-0.64%)
AbbVie to Buy Allergan: Prescribed ETFs

AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.

BMY : 55.53 (+0.58%)
AGN : 175.71 (-1.03%)
ABBV : 73.37 (-2.34%)
BBH : 128.32 (-0.77%)
PPH : 52.62 (-0.64%)
XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
PJP : 54.37 (-0.64%)
CELG : 108.24 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade PPH with:

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Key Turning Points

2nd Resistance Point 53.91
1st Resistance Point 53.27
Last Price 52.62
1st Support Level 52.07
2nd Support Level 51.51

See More

52-Week High 68.02
Fibonacci 61.8% 59.95
Fibonacci 50% 57.46
Fibonacci 38.2% 54.97
Last Price 52.62
52-Week Low 46.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar